Starpharma Holdings (ASX:SPL) has delivered a year of strategic focus and scientific progress, sharpening its efforts to extract long-term value from its proprietary dendrimer technology platform while strengthening its commercial foundations across oncology, women’s health and antiviral products. …
Starpharma advances dendrimer platform with clinical, commercial, and strategic progress
August 27, 2025 Australian Biotech
Latest Video
Georgia Forrest
New Stories
-
Anne Harris steps down after defining leadership during COVID and lasting impact on Medicines Australia
January 14, 2026 - - Latest News -
AusBiotech joins Trade Diversification Network to boost global life sciences partnerships
January 13, 2026 - - Australian Biotech -
Reread this document - even its redactions reveal that change might be coming
January 13, 2026 - - Latest News -
Johnson & Johnson the latest to sign 'Most Favored Nation' agreement with Trump administration
January 11, 2026 - - Latest News -
Reading between the reform lines - what the 2005 Cabinet papers can teach us today
January 11, 2026 - - Latest News -
New treatment listed on PBS, offering twice-yearly dosing for Australians with relapsing MS
January 9, 2026 - - Latest News -
The value of looking back and the importance of seeing the 'smoke signals' on reform
January 8, 2026 - - Latest News